LG Electronics Inc. grabbed a 13.9 percent share of the North American smartphone market in the second quarter, up 1.3 percentage points from the first quarter and 0.3 from last year.
A company official noted that although LG did not release its new smartphone in the second quarter, it increased its market share.
The official observed that LG's V60 ThinQ and budget smartphones took Chinese phones' sales in the market.
Chinese brands, such as Huawei, Oppo, and Xiaomi, have been losing their market share in North America due to tensions between the United States and China.
LG plans to release its 5G smartphone, the Velvet, in North America.
In the second quarter, LG's mobile business division posted an operating loss of 206.5 billion won, while sales declined 18.9 percent on-year to 1.31 trillion won.
According to Strategy Analytics, Apple Inc. was the topped the smartphone market in North America in the second quarter with a 36.8 percent share, trailed by Samsung Electronics Co. with 27.1 percent.


WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand
Google Secures Pentagon AI Deal for Classified Projects
Australia Targets Meta, Google, and TikTok With New News Payment Tax Proposal
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook
GameStop Eyes eBay Acquisition as Stock Prices Surge After Hours
Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance
Coles Group Q3 Sales Rise Driven by Supermarkets and E-Commerce Growth
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 



